Related Experiment Video
Updated: Jun 12, 2026
06:47
A Pulmonary Trunk Banding Model of Pressure Overload Induced Right Ventricular Hypertrophy and Failure
Published on: November 29, 2018
Left ventricular hypertrophy: an overlooked cardiovascular risk factor.
Michael A Bauml1, Donald A Underwood
1Department of Internal Medicine, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA. baumlm@ccf.org
Cleveland Clinic Journal of Medicine
|June 3, 2010
Summary
Left ventricular hypertrophy (LVH) is a common condition in hypertension patients that increases cardiovascular risks. Evidence suggests LVH is a modifiable risk factor, not solely dependent on blood pressure management.
Area of Science:
- Cardiology
- Hypertension Research
- Clinical Medicine
Background:
- Left ventricular hypertrophy (LVH) is a prevalent condition among patients with hypertension.
- LVH significantly elevates the risk of major adverse cardiovascular events, including myocardial infarction, stroke, and mortality.
- Emerging evidence highlights LVH as a modifiable risk factor, independent of complete blood pressure control.
Purpose of the Study:
- To provide a comprehensive review of left ventricular hypertrophy in hypertensive patients.
- To elucidate the underlying mechanisms (pathogenesis) of LVH development.
- To discuss current diagnostic strategies and therapeutic interventions for LVH.
Main Methods:
- Literature review of recent evidence on LVH pathogenesis, diagnosis, and treatment.
- Synthesis of current understanding regarding LVH in the context of hypertension.
- Analysis of factors contributing to LVH beyond blood pressure control.
Main Results:
- LVH is a significant predictor of cardiovascular morbidity and mortality in hypertensive individuals.
- Pathogenesis of LVH involves complex molecular and cellular mechanisms.
- Effective management strategies for LVH are crucial for improving patient outcomes.
Conclusions:
- Left ventricular hypertrophy is a critical, modifiable target in hypertensive patients.
- Comprehensive management of LVH requires addressing factors beyond blood pressure.
- Further research into LVH pathogenesis and treatment is warranted.
Related Concept Videos
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
01:20Mitral Regurgitation I: Introduction
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
01:26Imbalances in Cardiac Output
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
01:22Mitral Stenosis I: Introduction
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...